RecruitingNot ApplicableNCT06609148

Probiotic in Patients With Bile Acid Malabsorption/Diarrhea

Randomized, Double-Blind, Placebo-Controlled Trial of De Simone Formulation Probiotic in Patients With Bile Acid Malabsorption/Diarrhea Unassociated With Ileal Resection

Sponsor

Mayo Clinic

Enrollment

24 participants

Start Date

Jan 2, 2025

Study Type

INTERVENTIONAL

Conditions

Bile Acid Malabsorption Bile Acid Diarrhea

Summary

The purpose of this study is to assess effect of the DSF probiotic on fecal bile acid levels in patients with BAM.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying De Simone formulation probiotic and Placebo for people with bile acid diarrhea and bile acid malabsorption. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTDe Simone formulation probiotic

Subjects will be given De Simone formulation probiotic 900 billion CFU, 3 times per day for 21-24 days

DIETARY_SUPPLEMENTPlacebo

Subjects will be given a placebo for 21-24 days

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06609148

Related Trials

Treatment of Bile Acid Diarrhoea With Atorvastatin

NCT070421651 location

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

NCT074298641 location